Eosinophilic pneumonia prevention

Prevention of eosinophilic pneumonia

• Relapses occur in more than half the patients while decreasing or after stopping corticosteroids.
• Relapses typically can be treated with a dose of 20 mg per day of prednisone.
• Clinical and functional follow-up is necessary.
• Patients should be informed about the role of tobacco in the disease process and should be encouraged to quit.

References

Pneumonia Main Page
Eosinophilic pneumonia Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Eosinophilic pneumonia from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
Diagnostic Criteria
History and Symptoms
Physical Examination
Laboratory Findings
Chest X Ray
CT
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Eosinophilic pneumonia prevention On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Eosinophilic pneumonia prevention All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Eosinophilic pneumonia prevention
CDC onEosinophilic pneumonia prevention
Eosinophilic pneumonia prevention in the news
Blogs on Eosinophilic pneumonia prevention
Directions to Hospitals Treating Eosinophilic pneumonia
Risk calculators and risk factors for Eosinophilic pneumonia prevention